Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 1 of 1 for:    NCT02041468
Previous Study | Return to List | Next Study

Study to Evaluate Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02041468
Recruitment Status : Unknown
Verified August 2017 by Dr. Jason Agulnik, Jewish General Hospital.
Recruitment status was:  Active, not recruiting
First Posted : January 22, 2014
Last Update Posted : August 30, 2017
Quebec Clinical Research Organization in Cancer
Personalized Medicine Partnership for Cancer
Information provided by (Responsible Party):
Dr. Jason Agulnik, Jewish General Hospital

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : March 2018
Estimated Study Completion Date : June 2018
Publications automatically indexed to this study by Identifier (NCT Number):